A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.

Won Il JangSun Hyun BaeMi-Sook KimChul Ju HanSu Cheol ParkSang Bum KimEung-Ho ChoChul Won ChoiKyung Su KimSangyoun HwangJin Ho KimA Ram ChangYounghee ParkEun Seog KimWoo Chul KimSunmi JoHae Jin Park

Published in: Cancer (2019)

With a median follow-up of 41 months, this prospective multicenter study demonstrated that SBRT for patients with HCC is well tolerated and is an effective treatment modality.

Keyphrases

radiation therapy
early stage
locally advanced
radiation induced
combination therapy
replacement therapy